Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?

por Epperla, Narendranath, Vaughn, John L., Othus, Megan, Hallack, Abrahao, Costa, Luciano J.
Publicado 2020

Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies

por Othus, Megan, Sekeres, Mikkael A., Nand, Sucha, Garcia-Manero, Guillermo, Appelbaum, Frederick R., Erba, Harry P., Estey, Eli
Publicado 2018

Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

por Orvain, Corentin, Rodríguez-Arbolí, Eduardo, Othus, Megan, Sandmaier, Brenda M., Deeg, H. Joachim, Appelbaum, Frederick R., Walter, Roland B.
Publicado 2023

Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data

por Othus, Megan, Garcia-Manero, Guillermo, Godwin, John E., Weick, James K., Appelbaum, Frederick R., Erba, Harry P., Estey, Elihu H.
Publicado 2022

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

por Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Publicado 2012

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

por Shih, Lauren, Othus, Megan, Schonhoff, Kelda, Shaw, Carole, Appelbaum, Jacob, Halpern, Anna B., Becker, Pamela S., Walter, Roland B., Estey, Elihu, Percival, Mary-Elizabeth
Publicado 2023

Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia

por Othus, Megan, Wood, Brent L., Stirewalt, Derek L., Estey, Elihu H., Petersdorf, Stephen H., Appelbaum, Frederick R., Erba, Harry P., Walter, Roland B.
Publicado 2016

High frequency of brain metastases after adjuvant therapy for high‐risk melanoma

por Samlowski, Wolfram E., Moon, James, Witter, Merle, Atkins, Michael B., Kirkwood, John M., Othus, Megan, Ribas, Antoni, Sondak, Vernon K., Flaherty, Lawrence E.
Publicado 2017

Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML

por Sorror, Mohamed L., Agarwal, Shirali, Othus, Megan, Lynch, Ylinne, Nyland, Jennifer E., Percival, Mary‐Elizabeth, Becker, Pamela S., Appelbaum, Frederick R., Estey, Elihu H.
Publicado 2020

Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia

por Palmieri, Raffaele, Othus, Megan, Cheng, Guang-Shing, Buccisano, Francesco, Paterno, Giovangiacinto, Maurillo, Luca, Del Principe, Maria Ilaria, Sconocchia, Giuseppe, Venditti, Adriano, Walter, Roland B.
Publicado 2022

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute...

por Orvain, Corentin, Wilson, Jacob A., Fang, Min, Sandmaier, Brenda M., Rodríguez-Arbolí, Eduardo, Wood, Brent L., Othus, Megan, Appelbaum, Frederick R., Walter, Roland B.
Publicado 2022

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

por Zhou, Yi, Othus, Megan, Araki, Daisuke, Wood, Brent L., Radich, Jerald P., Halpern, Anna B., Mielcarek, Marco, Estey, Elihu H., Appelbaum, Frederick R., Walter, Roland B.
Publicado 2016

Utility of Treatment-Related Mortality (TRM) Score to Predict Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

por Zarling, Lucas C., Othus, Megan, Sandmaier, Brenda M., Milano, Filippo, Schoch, Gary, Davis, Chris, Bleakley, Marie, Deeg, H. Joachim, Appelbaum, Frederick R., Storb, Rainer, Walter, Roland B.
Publicado 2022

Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms

por Paras, Gabrielle, Othus, Megan, Schonhoff, Kelda, Shaw, Carole, Sorror, Mohamed, Halpern, Anna B., Appelbaum, Jacob, Hendrie, Paul, Walter, Roland B., Estey, Elihu H., Percival, Mary-Elizabeth M.
Publicado 2022

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 P...

por Eljilany, Islam, Noor, Arish, Paravathaneni, Mahati, Yassine, Ibrahim, Lee, Sandra J., Othus, Megan, Moon, James, Kirkwood, John M., Sondak, Vernon K., Ribas, Antoni, Grossmann, Kenneth F., Tarhini, Ahmad A.
Publicado 2023

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification

por Hochman, Michael J., Othus, Megan, Hasserjian, Robert P., Ambinder, Alex, Brunner, Andrew, Percival, Mary-Elizabeth M., Hourigan, Christopher S., Swords, Ronan, DeZern, Amy E., Estey, Elihu H., Karp, Judith E.
Publicado 2023

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell tra...

por Rodríguez-Arbolí, Eduardo, Othus, Megan, Orvain, Corentin, Zarling, Lucas C., Sandmaier, Brenda M., Milano, Filippo, Schoch, Gary, Davis, Chris, Deeg, H. Joachim, Appelbaum, Frederick R., Storb, Rainer, Walter, Roland B.
Publicado 2022

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML

por Morsink, Linde M., Othus, Megan, Bezerra, Evandro D., Wood, Brent L., Fang, Min, Sandmaier, Brenda M., Mielcarek, Marco, Schoch, Gary, Storb, Rainer, Joachim Deeg, H., Appelbaum, Frederick R., Walter, Roland B.
Publicado 2020

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

por Percival, Mary-Elizabeth M., Othus, Megan, Mirahsani, Sarah, Gardner, Kelda M., Shaw, Carole, Halpern, Anna B., Becker, Pamela S., Hendrie, Paul C., Sorror, Mohamed L., Walter, Roland B., Estey1, Elihu H.
Publicado 2020

Effect of Genetic Profiling on Prediction of Therapeutic Resistance and Survival in Adult Acute Myeloid Leukemia

por Walter, Roland B., Othus, Megan, Paietta, Elisabeth M., Racevskis, Janis, Fernandez, Hugo F., Lee, Ju-Whei, Sun, Zhuoxin, Tallman, Martin S., Patel, Jay, Gönen, Mithat, Abdel-Wahab, Omar, Levine, Ross L., Estey, Elihu H.
Publicado 2015